Advancements in super-selective catheterization and drug selection for intra-arterial chemotherapy for retinoblastoma: A 15-year evolution Journal Article
| Authors: | Kocharian, G.; Gobin, Y. P.; Kharas, N.; Knopman, J.; Francis, J. H.; Abramson, D. H. |
| Article Title: | Advancements in super-selective catheterization and drug selection for intra-arterial chemotherapy for retinoblastoma: A 15-year evolution |
| Abstract: | BackgroundRetinoblastoma (Rb) is the most common primary ocular malignancy of childhood. Left untreated, it is 100% fatal and carries a substantial risk of impaired vision and removal of one or both eyes. Intra-arterial chemotherapy (IAC) has become a pillar in the treatment paradigm for Rb that allows for better eye salvage and vision preservation without compromising survival. We describe the evolution of our technique over 15 years. MethodsA retrospective chart review was conducted of 571 patients (697 eyes) and 2391 successful IAC sessions over 15 years. This cohort was separated into three 5-year periods (P1, P2, P3) to assess trends in IAC catheterization technique, complications, and drug delivery. ResultsFrom a total of 2402 attempted IAC sessions, there were 2391 successful IAC deliveries, consistent with a 99.5% success rate. The rate of successful super-selective catheterizations over the three periods ranged from 80% in P1 to 84.9% in P2 and 89.2% in P3. Catheterization-related complication rates were 0.7% in P1, 1.1% in P2, and 0.6% in P3. Chemotherapeutics used included combinations of melphalan, topotecan and carboplatin. The rate of patients receiving triple therapy among all groups was 128 (21%) in P1, 487 (41.9%) in P2, and 413 (66.7%) in P3. ConclusionsThe overall rate of successful catheterization and IAC started high and has improved over 15 years, and catheterization-related complications are rare. There has been a significant trend towards triple chemotherapy over time. |
| Keywords: | melphalan; injection; tumor; management; technique; infusion; pediatrics; intraocular retinoblastoma; drug; orbit; ophthalmic artery chemotherapy |
| Journal Title: | Journal of Neurointerventional Surgery |
| Volume: | 16 |
| Issue: | 4 |
| ISSN: | 1759-8478 |
| Publisher: | BMJ Publishing Group Ltd. |
| Date Published: | 2024-04-01 |
| Start Page: | 398 |
| End Page: | 404 |
| Language: | English |
| ACCESSION: | WOS:000992073700001 |
| DOI: | 10.1136/jnis-2023-020109 |
| PROVIDER: | wos |
| PUBMED: | 37197934 |
| Notes: | Article -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work